实际关注豆类口服免疫疗法
Gilbert T Chua1, Edmond S Chan2,3
1From the Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong SAR, China.
Journal of food allergy
|July 18, 2024
概括
对非花生豆类过敏的口服免疫疗法 (OIT) 正在出现. 缺乏协议,但花生 OIT 数据表明适应其他豆类的方法,特别是在学龄前儿童.
科学领域:
- 食物过敏和免疫学 食物过敏和免疫学
- 临床营养和饮食学
背景情况:
- 豆类 (不包括花生) 是重要的蛋白质来源,由于健康益处和素食主义而增加消费.
- 豆类过敏,交叉敏感和交叉反应是公认的临床问题.
- 已建立的口服免疫疗法 (OIT) 对花生过敏的协议存在,但对其他豆类缺乏.
研究的目的:
- 审查目前口服免疫疗法 (OIT) 对非花生豆类过敏的现状.
- 探索花生国际贸易组织 (OIT) 协议对非花生豆类过敏的潜在适应.
- 确定研究缺口,并为非花生豆类 OIT.建议未来的方向.
主要方法:
- 对有关豆类过敏和OIT现有研究的文献综述.
- 对花生OIT数据进行分析,以对其他豆类进行潜在应用.
- 讨论实施豆类OIT的临床考虑.
主要成果:
- 对于非花生豆类 OIT 的公布协议很少.
- 花生 OIT 数据为适应其他豆类的协议提供了基础.
- 幼儿园儿童是OIT证明安全性和有效性的人口群体.
结论:
- 需要进一步的研究来确定非花生豆类OIT的安全性和有效性.
- 适应花生OIT协议是治疗非花生豆类过敏的合理方法.
- 对临床医生来说,在学龄前儿童中启动OIT可能是一个实际的起点.
相关概念视频
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immunological Memory
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...


